Physician profile
Eric R Mintalar
NPI 1447396759
$1,514.44
in general payments reported to CMS, 2019-2025
12 companies · $210 in 2025
The $210 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $425 · 2021: $355 · 2022: $226 · 2023: $46.93 · 2024: $131 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366 · Travel and Lodging: $21.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.15 |
| Travel and Lodging | $21.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $424.60 | 2020 | |
| Dentsply LLC | $250.00 | 2021 | |
| Straumann USA LLC | $194.01 | 2021-2022 | |
| Align Technology, INC. | $141.41 | 2023-2025 | Invisalign |
| Biohorizons Implant Systems INC. | $131.68 | 2023-2025 | Biohorizons Dental Implants, Biohorizons |
| Ultradent Products INC | $130.42 | 2022-2025 | Opalescence |
| Dentsply Ih INC. | $106.64 | 2019 | |
| Dentsply Sirona INC | $81.61 | 2019-2025 | X-Smart |
| Envista Holdings Corporation | $17.12 | 2024 | Maxcem Elite |
| Gc America INC. | $13.52 | 2024 | Everstick, Equia, Gc Initial |
| Elevate Oral Care | $13.43 | 2022 | |
| Coltene Whaledent INC. | $10.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Mintalar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.